Show results for
Refine by
Metabolic Disease Suppliers Serving Finland
43 companies found
based inPhiladelphia, PENNSYLVANIA (USA)
We are a biotechnology company at the forefront of advanced therapies to treat a range of devastating rare diseases. Amicus Therapeutics (Nasdaq:FOLD) is a global, patient-dedicated biotechnology company focused on discovering, developing and ...
based inWuhan, CHINA
Wuhan EasyDiagnosis Biomedicine Co., Ltd was established in Wuhan Optics Valley in 2008 and went public in 2018 (Shenzhen Stock Exchange code 002932), EasyDiagnosis is a Chinese national high-tech enterprise specializing in R&D, production and sales ...
based inBangalore, INDIA
Strand Life Sciences is a genomics-based research and diagnostics company with a mission to improve global health by decoding the genetic information contained in an individual’s genome. Strand Life Sciences partnership programs enable large-scale ...
based inCambridge, MASSACHUSETTS (USA)
Alnylam is the Leading RNAi Therapeutics Company. Alnylam has led the translation of RNAi (RNA interference) from Nobel Prize-winning discovery into an innovative, entirely new class of medicines. Founded in 2002 by a team of distinguished life ...
based inTokyo, JAPAN
Teijin Limited (Japan) is a global technology-driven company operating in six major fields: high-performance fibres (aramid fibres and carbon fibers), polyester fibres, films and plastics, pharmaceuticals and home health care, trading and retail, ...
Focusing on the three key therapeutic areas: bone and joint, respiratory, and cardiovascular and metabolic diseases, the Teijin Group is promoting global business expansion led by the twin driving forces of ...
based inCambridge, UNITED KINGDOM
Biochrom has a long history of making quality scientific instruments for a wide range of applications in the clinical, life-science and industrial markets.We are committed to remaining a world class company by the regular introduction of new, ...
Biochrom launches the Biochrom 30+ Series of amino acid analyzers - the gold standard in dedicated amino acid analysis. Clinical laboratories worldwide trust this well documented classical amino acid analysis method based on ion exchange ...
based inVancouver, BRITISH COLUMBIA (CANADA)
Aspect Biosystems is a privately held biotechnology company combining the power of microfluidics and 3D bioprinting to fuel medical research and the development of bioprinted therapeutics. By adopting Aspect™s microfluidic 3D bioprinting platform ...
based inLexington, MASSACHUSETTS (USA)
Fractyl Health is an organ editing metabolic therapeutics company focused on pioneering a new approach to the treatment of Type 2 Diabetes (T2D). Our goal is to transform T2D treatment from chronic blood glucose management to disease-modifying ...
Our lead product candidate, the Revita DMR System, or Revita®, is a first-in-class procedural therapy designed to target the duodenum as a root cause of type 2 diabetes. For people with advanced type 2 diabetes, the main form of therapy to ...
based inPlan-les-Ouates, SWITZERLAND
Adiposs is a biotech start-up company, a spin-off from the University of Geneva. The company is incorporated in the Canton of Geneva, Switzerland. Adiposs is developing first-in-class medical imaging products and technologies. Adiposs has developed ...
Adiposs has developed ImageBAT, the first product that makes brown and beige adipose tissue (BAT) visible with a fast and pain-free CT scan. It enables early detection of body wasting before patients lose body weight. The diagnostic procedure with ...
based inDwarka, INDIA
Everflow Global. We are a leading company engaged in water & air treatment using the bioremediation Process. We offer you the best technology in industrial wastewater treatment. Our cleantech solutions are focused on Carbon negative and ...
Astaxanthin pigment is produced by freshwater microalgae Haematococcus Pluvialis and also by some funguses. It is a keto-carotenoid group containing metabolites of zeaxanthin and canthaxanthin. Astaxanthin is well known for its antioxidant ...
based inMonmouth Junction, NEW JERSEY (USA)
MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use. We have professionally experienced and friendly staff to meet ...
Friedelin is also a competitive inhibitor of CYP2E1, with IC50 and Ki values of 22.54 μM and 18.02 μM, respectively. Friedelin can be used in research related to inflammation, neurological diseases, and metabolic ...
based inCambridge, MASSACHUSETTS (USA)
AOBiome has identified significant therapeutic opportunities caused by the adverse impact of the modern environment on human physiology. The human body relies on a system of multiple microorganisms, chemistries, and pathways which have shaped the ...
based inCambridge, MASSACHUSETTS (USA)
Founded in 2018 by a team of accomplished scientists with a proven track record in drug discovery and executive leadership in top global biopharmaceutical companies, Regor is a pioneering international biotech company with headquarters in Shanghai, ...
based inCambridge, MASSACHUSETTS (USA)
Seres Therapeutics is a late-clinical stage biotechnology company with a strong development pipeline and rigorous scientific underpinning, working to revolutionize treatment of a wide range of diseases by modulating the function of the human ...
based inBoston, MASSACHUSETTS (USA)
SOPHiA GENETICS is the creator of a global data-sharing network – we work with customers from over 790 institutions in over 70 countries. Our network advances data-driven medicine to improve health outcomes and economics worldwide. We offer a ...
Metabolic disorders are a major cause of morbidity and mortality, representing a growing health concern worldwide. Over the last decade, substantial progress has been made in the discovery of genetic variants influencing a range of ...
based inSeongnam-si, SOUTH KOREA
LISCure Biosciences Provides Novel Therapeutics to Patients with Refractory Diseases Using the LMT Platform. LISCure is developing the world’s first injectable immuno-oncology program using non-pathogenic microorganisms. We focus on the development ...
The LMT (LISCure Microbiology-based Technology) platform is an innovative tool to keep discovering and analyzing microbial and genome-based drug candidates. LMT (LISCure Microbiology-based Technology) Platform Consists of the Therapeutic Screening ...
based inAbercynon, UNITED KINGDOM
Imspex provides cutting-edge analytics solutions where early warning signals are needed. Our versatile combination of gas chromatography (GC) and ion mobility spectrometry (IMS) has already proven itself in medical detection and medical diagnosis ...
based inGreenfield, INDIANA (USA)
We're a leader in farm animal and pet health solutions, treating and preventing disease in more than 90 countries. A global animal health leader, we rigorously innovate to improve the health of animals, benefit our customers, support our causes and ...
based inNaarden, NETHERLANDS
Azafaros has leveraged on decades of discovery by professors Hans Aerts, Hermen Overkleeft, and Stan van Boeckel at Leiden University and the Academic Medical Center in the Netherlands. Expanding on their research and led by highly experienced ...
Lysosomal storage diseases (LSDs) are a group of over 70 diseases that are characterized by lysosomal dysfunction, most of which are inherited as autosomal recessive traits. These disorders are individually rare but collectively affect 1 in 5,000 ...
based inDuluth, GEORGIA (US) (USA)
The products that make up the BIVI portfolio help animals feel better, perform better and live better. A guiding principle of the Boehringer family has always been to provide Value through Innovation to our customers. We strive to provide our ...